Key result
Meal ingestion does not alter plasma ApoB levels, supporting reliable nonfasting measurement.
Why the study?
Postprandial lipemia is a risk marker for cardiovascular disease, and identifying factors affecting lipoprotein metabolism postprandially is important for prevention strategies.
Is there an association between obesity measurements and postprandial lipemia?
Comparison
Postprandial lipemia vs fasting lipemia in obese and non-obese subjects
Design
Cross-sectional study
Authors
Loading...
Obesity measures may link to postprandial lipemia but should not change practice; leaves open need for prospective cardiovascular outcome data.
Cross-Sectional (n=171)
No
Is there an association between obesity measurements and postprandial lipemia?
p-value: p=0.563 (females), 0.759 (males)
Apolipoprotein B levels are not affected by meal intake and can potentially replace LDL-C in lipid profile assessments, while postprandial lipemia correlates with obesity.
Baqi et al. (2018) conducted a cross-sectional in Obesity and Postprandial Lipemia (n=171). Meal ingestion (postprandial state) vs. Fasting state was evaluated on Apolipoprotein B levels (p=0.563 (females), 0.759 (males)). Meal ingestion significantly increased postprandial triglycerides but did not affect plasma apolipoprotein B levels, indicating ApoB can be reliably measured without fasting.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: